鄰近類別 圖書 [1/1] 會議論文/會議摘要 [16/27] 類別統計 近3年內發表的文件:23(34.85%) 含全文筆數:65(98.48%) 文件下載次數統計 下載大於0次:65(100.00%) 下載大於100次:63(96.92%) 檔案下載總次數:20378(77.95%) 最後更新時間: 2024-11-28 15:39 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Registry of genetic alterations of ... Systemic treatments in pancreatic c... The experience of neoadjuvant chemo... Real-world data validation of NAPOL... Elevated PD-L1 expression and micro... Adjuvant therapy in biliary tract c... The association between UGT1A1 poly... Revisiting the cerebral hemodynamic... A G-quadruplex stabilizer, CX-5461 ... Predictive value of albumin combine...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目26-50 / 66. (共3頁) << < 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2021-07-23	AUY922 induces retinal toxicity through attenuating TRPM1	Journal of Biomedical Science. 2021 Jul 23;28:Article number 55.
2021-07-15	No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol	Scientific Reports. 2021 Jul 15;11:Article number 14567.
2021-06-12	Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers	Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.
2021-06-07	In vivo assessment of hypoxia levels in pancreatic tumors using a dual-modality ultrasound/photoacoustic imaging system	Micromachines. 2021 Jun 7;12(6):Article number 668.
2021-05-14	Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma	PLoS ONE. 2021 May 14;16(5):Article number e0251811.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-01-13	Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials	Biomolecules. 2021 Jan 13;11(1):Article number 97.
2020-12-29	Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan	PLoS ONE. 2020 Dec 29;15(12):Article number e0244487.
2020-11-13	The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.]	Scientific Reports. 2020 Nov 13;10:Article number 20199.
2020-11-01	Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients	Sensors and Actuators B: Chemical. 2020 Nov 1;322:Article number 128569.
2020-10	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	Liver International. 2020 Oct;40(10):2535-2543.
2020-09-22	Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy	Radiation Oncology. 2020 Sep 22;15:Article number 221.
2020-08	Radiation dose escalation can improve local disease control and survival among esophageal cancer patients with large primary tumor volume receiving definitive chemoradiotherapy	PLoS ONE. 2020 Aug;15(8):Article number e0237114.
2020-05-26	Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan	Journal of Biomedical Science. 2020 May 26;27:Article number 69.
2020-05-04	The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort	Scientific Reports. 2020 May 4;10:Article number 7420.
2020-05	Impact of immune checkpoint inhibitors with or without a combination of tyrosine kinase inhibitors on organ-specific efficacy and macrovascular invasion in advanced hepatocellular carcinoma	Oncology Research and Treatment. 2020 May;43(5):211-220.
2020-05	Exploring Circulating Tumor Cells in cholangiocarcinoma using a novel glycosaminoglycan probe on a microfluidic platform	Advanced Healthcare Materials. 2020 May;9(10):Article number 1901875.
2020-02-27	Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer	Radiation Oncology. 2020 Feb 27;15:Article number 48.
2020-01	Review of preclinical and clinical studies of using cell-based therapy for secondary lymphedema	Journal of Surgical Oncology. 2020 Jan;121(1):109-120.
2020-01	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study	European Journal of Cancer. 2020 Jan;124:123-130.
2019-10-05	Percutaneous computed tomography-guided coaxial core biopsy for the diagnosis of pancreatic tumors	Journal of Clinical Medicine. 2019 Oct 5;8(10):Article number 1633.
2019-06-10	Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma	BMC Cancer. 2019 Jun 10;19:Article number 560.
2017-09	Screening of peptide specific to cholangiocarcinoma cancer cells using an integrated microfluidic system and phage display technology	Microfluidics and Nanofluidics. 2017 Sep;21(9):Article number 145.
2017-07-01	Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform	Biomicrofluidics. 2017 Jul 1;11(4):Article number 044101.

顯示項目26-50 / 66. (共3頁) << < 1 2 3 > >> 每頁顯示[10|25|50]項目